Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 10/25/2025

High-Intensity Statin Therapy with Rosuvastatin

Patient Selection and Dosing

  • High-intensity rosuvastatin therapy is defined as 20-40 mg daily, which achieves ≥50% reduction in LDL cholesterol, and is suitable for patients with severe hypercholesterolemia or established ASCVD requiring aggressive secondary prevention 1, 2, 3
  • The American College of Cardiology guidelines specifically identify rosuvastatin 20 mg and 40 mg as high-intensity statin doses evaluated in randomized controlled trials that demonstrated reduction in major cardiovascular events 2
  • Rosuvastatin 40 mg is appropriate for adults with severe hypercholesterolemia (LDL-C ≥190 mg/dL) requiring maximal LDL-C reduction, and for patients with established ASCVD requiring aggressive secondary prevention 1, 2, 4
  • Adults with heterozygous familial hypercholesterolemia who need intensive lipid lowering may also be treated with rosuvastatin 40 mg 4

Clinical Context and Efficacy

  • The use of rosuvastatin 40 mg is supported by clinical guidelines, including those from the American College of Cardiology, for patients requiring high-intensity statin therapy 2
  • Rosuvastatin 40 mg has been shown to achieve significant reductions in LDL cholesterol and improve cardiovascular outcomes in patients with severe hypercholesterolemia or established ASCVD 1, 2, 4